This financing builds on Centivax's $45 million oversubscribed Series A completed in June 2025, led by Steve Jurvetson of Future Ventures, with participation from BOLD Capital Partners, Kendall ...
Private equity firm Blackstone has said that its latest life sciences fund – BXLS VI – has closed with a total of $6.3 ...
Researchers led by the Fisabio Foundation found that dermcidin, a natural antimicrobial peptide present in sweat and ...
The FDA has granted Fast Track designation to BW-20805, an investigational small interfering RNA therapy for hereditary angioedema.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results